CAS NO: | 131740-09-5 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | Flavopiridol Hydrochloride (Alvocidib Hydrochloride) is a broad inhibitor ofCDK, competing with ATP to inhibit CDKs includingCDK1,CDK2,CDK4withIC50s of 30, 170, 100 nM, respectively. | ||||||||||||||||
IC50& Target[3] |
| ||||||||||||||||
体外研究 (In Vitro) | Flavopiridol (2 μM) robustly induces a distinct pattern of ER stress in CLL cells that contributes to cell death through IRE1-mediated activation of ASK1 and possibly downstream caspases[1]. Flavopiridol results in potent upregulation of a number of PRGs in treatments lasting 4-24 h. Flavopiridol has and immediate and long-term effect on the expression of several PRGs. In serum starved cells re-stimulated with serum, flavopiridol also inhibits the expression of these genes, but subsequently, JUNB, GADD45B and EGR1 are upregulated in the presence of flavopiridol[2]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 438.30 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C21H21Cl2NO5 | ||||||||||||||||
CAS 号 | 131740-09-5 | ||||||||||||||||
中文名称 | 夫拉平度盐酸盐 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 20 mg/mL(45.63 mM) H2O : ≥ 20 mg/mL(45.63 mM) DMF : 7.69 mg/mL(17.55 mM;Need ultrasonic) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|